Advertisement
Original Contribution
JAMA. 1964;190(2):99-103. doi: 10.1001/jama.1964.03070150009002

Dengue Fever: A Thrombocytopenic Disease?

  1. Ethel R. Nelson, MD;
  2. Howard R. Bierman, MD
  1. Bangkok, Thailand; Beverly Hills, Calif
  2. From Bangkok Sanitarium and Hospital (Dr. Nelson) and the Institute for Cancer and Blood Research (Dr. Bierman).

Abstract

In a study of dengue fever in Thailand, bone-marrow examinations showed hypocellularity early in the disease, followed by hypercullarity during recovery and normocellularity in convalescence. Thrombocytopenia due to megakaryocytic suppression was a characteristic. In 18 patients with early dengue, thrombocytopenia lasted one to four days; platelet counts in 8 were less than 50,000/cu cm. Petechiae or other bleeding manifestations were noted in 15 patients. Intensive hematologic studies of dengue infections in other geographic areas are suggested, to determine if thrombocytopenia is a universal characteristic of this and related virus diseases.

Footnotes

  • Reprint requests to 321 S Robertson Blvd, Beverly Hills, Calif (Dr. Bierman).

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals